We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that FDA has approved Rezipres (ephedrine hydrochloride injection) for the treatment of clinically important hypotension occurring in the setting of anesthesia.
Eton Pharmaceuticals announced Biorphen®, the first and only FDA-approved ready-to-use formulation of phenylephrine for the treatment of clinically important hypotension ...
In adults with recent stroke, a lower systolic blood pressure (SBP) goal may reduce the risk for orthostatic hypotension (OH) without any effect on orthostatic symptoms...